Two papers《VIPS》and《Cosmo》are accepted to in MobiCom'22, and《VIPS》won Best Paper Award Runner-Up. There are 317 submissions, of which only 56 articles are accepted. For details, click here.

Two papers《BlastNet》and《AutoMatch》are accepted to in Sensys'22. There are 209 submissions, of which only 52 articles are accepted.

The interdisciplinary research team lead by Prof. XING Guoliang of the Chinese University of Hong Kong (CUHK) has recently received funding from the Alzheimer’s Drug Discovery Foundation (ADDF) and SenseTime Technology (SenseTime) to develop Research and development of digital biomarkers for Hymer's disease. For details, click here.